Skip to main content

Achalasia and Esophageal Outlet Obstruction

  • Chapter
  • First Online:
Gastrointestinal Motility Disorders

Abstract

Achalasia is an uncommon motility disorder of the esophagus that is characterized by impaired lower esophageal sphincter (LES) relaxation and, in many cases, failure of peristalsis. Although the cause is unknown, it is thought to arise from the loss of myenteric neurons in the esophagus from an aberrant immune response in a genetically susceptible host. The resultant stasis of ingested food results in dysphagia, chest pain, and weight loss. The Chicago Classification for High Resolution Manometry (HRM) has categorized patients with achalasia into three diagnostic categories. The key finding is impaired LES relaxation as indicated by raised “integrated relaxation pressure (IRP > 15 mm Hg). Type I “classic” achalasia, often with luminal dilatation and little pressure activity in the esophageal body, Type II displays “pan-esophageal pressurization” on swallowing, and Type III “vigorous” achalasia is accompanied by spasm.

There is no cure for achalasia. Thus, treatment aims to disrupt the muscle fibers of the LES to improve esophagogastric junction (EGJ) opening and bolus passage. Pneumatic dilation and surgical myotomy combined with an antireflux procedure are established treatments that have shown comparable treatment outcomes in clinical studies. In recent years, per-oral endoscopic myotomy (POEM) has been introduced and has shown promising short-term results.

Esophagogastric junction outflow obstruction (EGJOO) is a recently described clinical entity categorized as impaired EGJ function with, at least in part, preserved esophageal contractility (i.e., without typical features of achalasia). The sensitivity of HRM for EGJOO is increased by inclusion of adjunctive tests (e.g., solid test meal). Technology to assess reduced EGJ distensibility (e.g., EndoFLIP) at endoscopy has also been described. After exclusion of a structural obstruction (e.g., eosinophilic esophagitis, tight fundoplication), treatment for functional EGJOO is similar to achalasia although large-scale clinical studies and long-term outcome data on EGJOO are awaited.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lendrum FC. Anatomic features of the cardiac orifice of the stomach with special reference to cardiospasm. Arch Intern Med. 1937;59:474–51.

    Article  Google Scholar 

  2. Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guidelines: diagnosis and management of achalasia. Am J Gastroenterol. 2013;108:1238–49.

    Article  PubMed  Google Scholar 

  3. Goldblum JR, Whyte RI, Orringer MB, et al. Achalasia: a morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18:327–37.

    Article  CAS  PubMed  Google Scholar 

  4. Boeckxstaens GE. Achalasia: virus induced euthanasia of neurons. Am J Gastroenterol. 2008;103:1610–2.

    Article  PubMed  Google Scholar 

  5. Becker J, Niebisch S, Ricchiuto A, et al. Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiophatic achalasia. Eur J Gastroenterol Hepatol. 2016;28:689–95.

    Article  PubMed  Google Scholar 

  6. Jung KW, Yoon IJ, Kim dH, et al. Genetic evaluation of ALADIN gene in early onset achalasia and alacrima patients. Neurogastroenterol Motil. 2011;17:169–73.

    Article  Google Scholar 

  7. De Oliveira RB, Rezende Filho J, Dantas RO, et al. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol. 1995;90:1119–24.

    PubMed  Google Scholar 

  8. Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313(18):1841–52.

    Article  PubMed  Google Scholar 

  9. Pandolfino JE, Kahrilas PJ. Perspectives in clinical gastroenterology and hepatology. Presentation, diagnosis and management of achalasia. Clin Gastroenterol Hepatol. 2013;11:887–97.

    Article  PubMed  Google Scholar 

  10. Kahrilas PJ, Boeckxstaens G. The spectrum of achalasia: lessons from studies of pathophysiology and high resolution manometry. Gastroenterol. 2013;145:954–65.

    Article  Google Scholar 

  11. Gockel I, Eckardt VF, Schmitt T, et al. Pseudoachalasia: a case series and analysis of the literature. Scand J Gastroenterol. 2005;40:378–85.

    Article  PubMed  Google Scholar 

  12. Mayberry JF. Epidemiology and demographics of achalasia. Gastrointest Endosc Clin N Am. 2001;11:235–48.

    CAS  PubMed  Google Scholar 

  13. Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterol. 1999;116:1300–4.

    Article  CAS  Google Scholar 

  14. Tsuboi K, Hoshino M, Srinivasan A, Yano F, Hinder RA, DeMeester T, Filipi C, Mittal SK. Insights gained from symptom evaluation of esophageal motility disorders: a review of 4215 patients. Digestion. 2012;85:236–42.

    Article  PubMed  Google Scholar 

  15. Sinan H, Tatum RP, Soares RV, Martin AV, Pellegrini CA, Oelschlager BK. Prevalence of respiratory symptoms in patients with achalasia. Dis Esophagus. 2011;24:224–8.

    Article  CAS  PubMed  Google Scholar 

  16. Fisichella PM, Raz D, Palazzo F, Niponmick I, Patti MG. Clinical, radiological and manometric profile in 145 patients with untreated achalasia. World J Surg. 2008;32:1974–9.

    Article  PubMed  Google Scholar 

  17. Kessing BF, Bredenoord AJ, Smout AJ. Erroneous diagnosis of gastroesophageal reflux disease in achalasia. Clin Gastroenterol Hepatol. 2011;9:1020–4.

    Article  PubMed  Google Scholar 

  18. Spechler SJ, Souza RF, Rosenberg SJ, Ruben RA, Goyal RK. Heartburn in patients with achalasia. Gut. 1995;37:305–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ponce J, Ortiz V, Maroto N, Bostamante M, Garriques V. High prevalence of heartburn and low acid sensitivity in patients with idiopathic achalasia. Dig Dis Sci. 2011;56:773–6.

    Article  PubMed  Google Scholar 

  20. Anderson SH, Yadegarfar G, Arastu MH, Anggiansah R, Anggiansah A. The relationship between gastroesophageal reflux symptoms and achalasia. Eur J Gastroenterol Hepatol. 2006;18(4):369–74.

    Article  PubMed  Google Scholar 

  21. Huselmans M, et al. Long term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8:30–5.

    Article  Google Scholar 

  22. Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144:718–25.

    Article  PubMed  Google Scholar 

  23. Gupta M, Ghoshal UC, Jindal S, Misra A, Nath A, Saraswat VA. Respiratory dysfunction is common in patients with achalasia and improves after pneumatic dilation. Dig Dis Sci. 2014;59:744–52.

    Article  CAS  PubMed  Google Scholar 

  24. Scherer JR, Kwiatek MASoper NJ, Pandolfino JE. Functional esophagogastric junction obstruction with intact peristalsis: a heterogenous syndrome sometimes akin to achalasia. J Gastrointest Surg. 2009;13(12):2219–25.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Van Hoeij FB, Smout AJ, Bredenoord AJ. Characterization of idiopathic esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2015;27:1310–6.

    Article  PubMed  Google Scholar 

  26. Perez-Fernandez MT, Santander C, Marinero A, Burgos-Santamaria D, Chavarria-Herbozo C. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil. 2016;28:116–26.

    Article  PubMed  Google Scholar 

  27. Clayton SB, Patel R, Richter JE. Functional and anatomic esophagogastric junction outflow obstruction: manometry, time barium esophagoagram findings and treatment outcomes. Clin Gastroenterol Hepatol. 2016;14:907–11.

    Article  PubMed  Google Scholar 

  28. Mittal RK, Kassab G, Puckett JL, et al. Hypertrophy of the muscularis propria of the lower esophageal sphincter and the body of the esophagus in patients with primary motility disorders of the esophagus. Am J Gastroenterol. 2003;98:1705–12.

    Article  PubMed  Google Scholar 

  29. Triadafilopoulos G, Boeckxstaens GE, Gullo R, Patti MG, Pandolfino JE, Kahrilas PJ, Duranceau A, Gamieson G, Zaninotto G. The Kagoshima consensus on esophageal achalasia. Dis Esophagus. 2012;25:337–48.

    Article  CAS  PubMed  Google Scholar 

  30. Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilatation. Gut. 2011;60:869–76.

    Article  PubMed  Google Scholar 

  31. Kahrilas PJ. Esophageal motor disorders in terms of high resolution esophageal pressure topography: what has changed? Am J Gastroenterol. 2010;105:981–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Clouse RE, Staiano A, Alrakawi A, et al. Application of topographical methods to clinical esophageal manometry. Am J Gastroenterol. 2000;95:2720–30.

    Article  CAS  PubMed  Google Scholar 

  33. Kahrilas PJ, Bredenoord AJ, Fox M, et al. International high resolution manometry working group: the Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.

    Article  CAS  PubMed  Google Scholar 

  34. Fox MR, Pandolfino JE, Sweis R, Sauter M, Abreu Y, Abreu AT, Anggiansah A, et al. Inter-observer agreement for diagnosis and classification of esophageal motility disorders defined in high resolution manometry. Dis Esophagus. 2015;28(8):711–9.

    Article  CAS  PubMed  Google Scholar 

  35. Carlson DA, Ravi K, Kahrilas PJ, Gyawali CP, Bredenoord AJ, Castell DO, et al. Diagnosis of esophageal motility disorders: esophageal pressure topography vs conventional line tracing. Am J Gastroenterol. 2015;110(7):967–77.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry:a quantitative analysis of 400 patients and 75 controls. Am J Phys. 2007;293:G878–85.

    CAS  Google Scholar 

  37. Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high resolution manometry. Gastroenterology. 2008;135:1526–33.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Bogte A, Bredenoord AJ, Oors J, Siersema PD, Smout AJ. Relationship between esophageal contraction patterns and clearance of swallowed liquid and solid boluses in healthy controls and patients with dysphagia. Neurogastroenterol Motil. 2012;24:e364–72.

    Article  CAS  PubMed  Google Scholar 

  39. Pouderoux P, Shi G, Tatum RP, Kahrilas PJ. Esophageal solid bolus transit: studies using concurrent videofluoroscopy and manometry. Am J Gastroenterol. 1999;94:1457–63.

    Article  CAS  PubMed  Google Scholar 

  40. Fox MR, Bredenoord AJ. Esophageal high resolution manometry: moving from research into clinical practice. Gut. 2008;57:405–23.

    Article  CAS  PubMed  Google Scholar 

  41. Ang D, Hollenstein M, Misselwitz B, Knowles K, Wright J, Tucker E, Sweis R, Fox M. Rapid drink challenge in high resolution manometry: an adjunctive test for detection of esophageal motility disorders. Neurogastroenterol Motil 2017;29(1).doi:10.1111/nmo. 12902.

  42. Sweis R, Anggiansah A, Wong T, Brady G, Fox M. Assessment of esophageal dysfunction and symptoms during and after a standardized test meal: development and clinical validation of a new methodology utilizing high-resolution manometry. Neurogastroenterol Motil. 2014;26(2):215–28.

    Article  CAS  PubMed  Google Scholar 

  43. Wang YT, Tai LF, Yakazi E, et al. Investigation of dysphagia after antireflux surgery by high-resolution manometry: impact of multiple water swallows and a solid test meal on diagnosis, management and clinical outcome. Clin Gastroenterol Hepatol. 2015;13:1575–83.

    Article  PubMed  Google Scholar 

  44. Pandolfino JE, Ruigh AD, Nicodeme F, Xiao Y, Boris L, Kahrilas P. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP™) in achalasia patients. Neurogastroenterol Motil. 2013;25:496–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Rohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of treatment for patients with achalasia depnds on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143:328–35.

    Article  PubMed  Google Scholar 

  46. Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFlip). Gastrointeset Endosc. 2010;72:272–8.

    Article  Google Scholar 

  47. Carlson DA, Lin Z, Kahrilas PJ, Sternbach J, Donnan EN, Friesen L, Listernick Z, Mogni B, Pandolfino JE. The functional lumen imaging probe detects esophageal contractility not observed with manometry in patients with achalasia. Gastroenterology. 2015;149:1742–51.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Boeckxstaens GE, Tack J, Zaninotto G. Achalasia: pneumatic dilatation or laparoscopic heller myotomy? J Gastrointest Surg. 2012;16:1284–5.

    Article  CAS  PubMed  Google Scholar 

  49. Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology. 1982;83(5):963–9.

    CAS  PubMed  Google Scholar 

  50. Bortolotti M, Mari C, Lopilato C, et al. Effects of sildenafil on esophageal motility in patients with idiopathic achalasia. Gastorenterology. 2000;118:253–7.

    Article  CAS  Google Scholar 

  51. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Kalloo AN. Intrasphincteric botolinum toxin for the treatment of achalasia. N Engl J Med. 1995;332:774–8.

    Article  CAS  PubMed  Google Scholar 

  52. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, An K. Botulinum toxin for achalasia: long term outcome and predictors of response. Gastroenterology. 1996;110(5):1410–5.

    Article  CAS  PubMed  Google Scholar 

  53. Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249:45–57.

    Article  PubMed  Google Scholar 

  54. Smith CD, Stival A, Howell DL, et al. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone. Ann Surg. 2006;243:579–84.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Kadakia SC, Wong RK. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol. 1993;88:34–8.

    CAS  PubMed  Google Scholar 

  56. Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilatation. Gastroenterology. 1992;103:1732–8.

    Article  CAS  PubMed  Google Scholar 

  57. Tack J, Janssens J, Vantrappen G. Non-surgical treatment of achalasia. Hepato-Gastroenterology. 1991;38:493–7.

    CAS  PubMed  Google Scholar 

  58. Rohof WO, Lei A, Boeckxstaens GE. Esophageal stasis on a time barium esophagogram predicts recurrent symptoms in patients with long standing achalasia. Am J Gastroenterol. 2013;108:49–55.

    Article  CAS  PubMed  Google Scholar 

  59. Vaezi MF, Baker ME, Achkar E, et al. Time barium esophagram: better predictor of long term success after pneumatic dialation in achalasia than symptom improvement. Gut. 2002;50:765–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Vaezi MF, Baker ME, Richter JE. Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram. Am J Gastroenterol. 1999;94:1802–7.

    Article  CAS  PubMed  Google Scholar 

  61. Farhoomand K, Connor JT, Richter JE, et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004;2:389–94.

    Article  PubMed  Google Scholar 

  62. Boeckxstaens GE, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364:1807–16.

    Article  CAS  PubMed  Google Scholar 

  63. Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4:580–7.

    Article  PubMed  Google Scholar 

  64. West RL, et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol. 2002;97:1346–51.

    Article  CAS  PubMed  Google Scholar 

  65. Lynch KL, Pandolfino JE, Howden CW, Kahrilas PJ. Major complications of pneumatic dilatation and Heller myotomy for achalasia: single centre experience and systematic review of the literature. Am J Gastroenterol. 2012;107(12):1817–25.

    Article  PubMed  Google Scholar 

  66. Vanuytsel T, et al. Conservative management of esophageal perforations during pneumatic dilation for idiopathic esophageal achalasia. Clin Gastroenterol Hepatol. 2012;10:142–9.

    Article  PubMed  Google Scholar 

  67. Ali A, Pellegrini CA. Laparoscopic myotomy: technique and efficacy in treating achalasia. Gastrointest Endosc Clin N Am. 2011;11:347–58.

    Google Scholar 

  68. Salvador R, et al. Laparoscopic Heller myotomy can be used as primary therapy for esophageal achalasia regardless of age. J Gastrointest Surg. 2014;18:106–11.

    Article  PubMed  Google Scholar 

  69. Rawlings A, Soper NJ, Oelschlager B, et al. Laparoscopic Dor versus Toupet fundoplication following Heller myotomy for achalasia: results of a multicenter, prospective, randomized controlled trial. Surg Endosc. 2012;26(1):18–26.

    Article  PubMed  Google Scholar 

  70. Richards WO, Torquati A, Holzman MD, et al. Heller myotomy versus heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg. 2004;240(3):401–12.

    Article  Google Scholar 

  71. Salvador R, Pesenti E, Gobbi L, et al. Postoperative gastroesophageal reflux after laparoscopic Heller-Dor for achalasia: true incidence with an objective evaluation. J Gastrointest Surg. 2017;21:17–22.

    Article  PubMed  Google Scholar 

  72. Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet. 2014;383:83–93.

    Article  PubMed  Google Scholar 

  73. Persson J, Johnsson E, KOstic S, Lundell L, Smedh U. Treatment of achalasia with laparoscopic myotomy or pneumatic dilatation: long term results of a prospective randomized study. World J Surg. 2015;39(3):713–20.

    Article  PubMed  Google Scholar 

  74. Torquati A, Richards WO, Holzman MD, Sharp KW. Laparoscopic myotomy for achalasia: predictors of successful outcome after 200 cases. Ann Surg. 2006;243:597–1.

    Article  Google Scholar 

  75. Schuchert MJ, et al. Minimally invasive esophagectomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann Thorac Surg. 2008;85:1729–34.

    Article  PubMed  Google Scholar 

  76. Zaninotto G, et al. Four hundred laparoscopic myotomies for esophageal achalasia; a single centre experience. Ann Surg. 248:986–33.

    Google Scholar 

  77. Pasricha PJ, Hawari R, Ahmed I, et al. Submucosal endoscopic esophageael myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy. 2007;39(9):761–4.

    Article  CAS  PubMed  Google Scholar 

  78. Inoue H, Minami H, Kobayashi Y. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71.

    Article  CAS  PubMed  Google Scholar 

  79. von Renteln D, Inoue H, Minami H, et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single centre study. Am J Gastroenterol. 2012;107:411–7.

    Article  Google Scholar 

  80. Hungness ES, Teitelbaum EN, Santos BF, et al. Comparison of perioperative outcomes between peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy. J Gastrointest Surg. 2013;17:228–35.

    Article  PubMed  Google Scholar 

  81. Stavropoulos SN, Modayil RJ, Friedel D, et al. The International Per Oral Endoscopic Myotomy Survey (IPOEMS): a snapshot of the global POEM experience. Surg Endosc. 2013;27:3322–38.

    Article  PubMed  Google Scholar 

  82. Bredenoord AJ, Rosch T, Fockens P. Peroral endoscopic myotomy for the treatment of achalasia. Neurogastroenterol Motil. 2014;26:3–12.

    Article  CAS  PubMed  Google Scholar 

  83. von Renteln D, Fuchs KH, Fockens P, et al. Peroral endoscopic myotomy for the treatment of achalasia; an international prospective multicenter study. Gastroenterology. 2013;145:309–11.

    Article  Google Scholar 

  84. Patel K, Abbassi-Ghadi N, Markar S, Kumar S, Jethwa P, Zaninotto G. Peroral endoscopic myotomy for the treatment of esophageal achalasia: systematic review and poolyed analysis. Dis Esophagus. 2016;29:807–19.

    Article  CAS  PubMed  Google Scholar 

  85. Familiari P, Greco S, Gigante G, Cali A, Boskoski I, Onder G, Perri V, Costamagna G. Gastroesophageal reflux disease after peroral endoscopic myotomy: analysis of clinical, procedural and functional factors associated with gastroesophageal reflux disease and esophagitis. Dig Endosc. 2016;28:33–41.

    Article  PubMed  Google Scholar 

  86. Sharata A, Kurian AA, Dunst CM, Bhayani NH, Reavis KM, Swanstrom LL. Peroral endoscopic myotomy is safe and effective in the setting of prior endoscopic intervention. J Gastrointest Surg. 2013;17:1188–92.

    Article  PubMed  Google Scholar 

  87. Ling T, Guo H, Zou X. Peroral endoscopic myotomy is effective for achalasia patients with failure of prior pneumatic dilation: a prospective case control study. J Gastroenterol Hepatol. 2014;29:1609–13.

    Article  PubMed  Google Scholar 

  88. Zhou PH, Li QL, Yao LQ, MD X, Chen WF, Cai MY, JW H, Li L, Zhang YQ, Zhong YS, Ma LL, Qin WZ, Cui Z. Peroral endoscopic remyotomy for failed Heller myotomy: a prospective single centre study. Endoscopy. 2013;45(3):161–6.

    Article  CAS  PubMed  Google Scholar 

  89. Vigneswaran Y, Yetasook AK, Zhao JC, Denham W, Linn JG, Ujiki MB. Peroral endoscopic myotomy (POEM): feasible as reoperation following Heller myotomy. J Gastrointest Surg. 2014;18(6):1071–6.

    Article  PubMed  Google Scholar 

  90. Onimaru M, Inoue H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, Santi EG, Grimes KL, Ito H, Kudo SE. Greater curvature myotomy is a safe and effective modified technique in per-oral endoscopic myotomy (with videos). Gastrointest Endosc. 2015;81(6):1370–7.

    Article  PubMed  Google Scholar 

  91. Werner YB, Costamagna G, Swanstrom L, von Renteln D, Familiari P, Sharata AM, Noder T, Schachschal G, Kersten JF, Rosch T. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow up of 2 years. Gut. 2016;65:899–906.

    Article  PubMed  Google Scholar 

  92. Bechara R, Ikeda H, Inoue H. Peroral endoscopic myotomy: an evolving treatment for achalasia. Nat Rev Gastroenterol Hepatol. 2015;12:410–26.

    Article  PubMed  Google Scholar 

  93. Duranceau A, Liberman M, Martin J, et al. End-stage achalasia. Dis Esophagus. 2012;25:319–30.

    Article  CAS  PubMed  Google Scholar 

  94. Mineo TC, Ambrogi V. Long term results and quality of life after surgery for esophageal achalasia: one surgeon’s experience. Eur J Cardiothorac Surg. 2004;25:1089–96.

    Article  PubMed  Google Scholar 

  95. Sweet MP, Nipomnick I, Gasper WJ, et al. The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation. J Gastrointest Surg. 2008;12:159–65.

    Article  PubMed  Google Scholar 

  96. Glatz SM, Richardson JD. Esophagectomy for end stage achalasia. J Gastointest Surg. 2007;11:1134–7.

    Article  Google Scholar 

  97. Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci. 2009;54:2303–11.

    Article  CAS  PubMed  Google Scholar 

  98. Leyden JE, Moss AC, MacMathuna P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev. 2014;12:CD005046.

    Google Scholar 

  99. Annese V, Basciani M, Perri F, Lombardi G, Frusciante V, Simone P, Andriulli A, Vantrappen G. Controlled tiral of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology. 1996;111:1418–24.

    Article  CAS  PubMed  Google Scholar 

  100. Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL, Koehler RE, Baker ME. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomized trial. Gut. 1999;44(2):231–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Muehldorfer SM, Schneider TH, Hochberger J, Martus P, Hahn EG, Ell C. Esophageal achalasia: intrasphincteric injection of botulinum toxin a versus balloon dilation. Endoscopy. 1999;31(7):517–21.

    Article  CAS  PubMed  Google Scholar 

  102. Prakash C, Freedland KE, Chan MF, Clouse RE. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol. 1999;94(2):328–33.

    Article  CAS  PubMed  Google Scholar 

  103. Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther. 2001;15(9):1389–96.

    Article  CAS  PubMed  Google Scholar 

  104. Ghoshal UC, Chaudhuri S, Pal BB, Dhar K, Ray G, Banerjee PK. Randomized controlled trial of intrasphincteric botulinum toxin a injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus. 2001;14(3–4):227–31.

    Article  CAS  PubMed  Google Scholar 

  105. Allescher HD, Storr M, Siege M, Gonzales-Donoso R, Ott R, Born P, Frimberger E, Weigert N, Stier A, Kurjak M, Rosch T, Classen M. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation: a prospective study with long term follow up. Endoscopy. 2001;33(12):1007–17.

    Article  CAS  PubMed  Google Scholar 

  106. Bansal R, Nostrant T, Scheiman J, Koshy S, Barnett J, Elta G, Chey W. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol. 2003;36(3):209–14.

    Article  CAS  PubMed  Google Scholar 

  107. Yaghoobi M, Mayrand S, Martel M, Roshan-Afshar I, Bijarchi R, Barkun A. Laparoscopic Heller myotomy vs pneumatic dilatation in the treatment of idiophatic achalasia: a meta-analysis of randomized controlled trials. Gastrointest Endosc. 2013;78:468–75.

    Article  PubMed  Google Scholar 

  108. Schoenberg B, et al. Laparoscopic Heller myotomy versus endoscopic balloon dilatation for the treatment of achalasia: a network meta-anaslysis. Ann Surg. 2013;258:943–52.

    Article  PubMed  Google Scholar 

  109. Moonen A, Annese V, Belmans A, Bredenoord A, et al. Long-term results of the European achalasia trial: a multicenter randomized controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65:732–9.

    Article  PubMed  Google Scholar 

  110. Novais PA, Lemme EM. 24 hour pH monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomy. Aliment Pharm Ther. 2010;32(10):1257–65.

    Article  CAS  Google Scholar 

  111. Kostic S, Kjellin A, Ruth M, Lonroth H, Johnsson E, Andersson M, Lundell L. Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. World J Surg. 2007;31:470–8.

    Article  CAS  PubMed  Google Scholar 

  112. Lopushinsky SR, Urbach DR. Pneumatic dilatation and surgical myotomy for achalasia. JAMA. 2006;296(18):2227–33.

    Article  CAS  PubMed  Google Scholar 

  113. Suarez J, Mearin F, Boque R, Zanon V, Armengol JR, Pradell J, Bermejo B, Nadal A. Laparoscopic myotomy vs endoscopic dilation in the treatment of achalasia. Surg Endosc. 2002;16:75–7.

    Article  CAS  PubMed  Google Scholar 

  114. Borges AA, Lemme EM, Abrahao LJ, Madureira D, Andrade MS, Soldan M, Helman L. Pneumatic dilation versus laparoscopic Heller myotomy for the treatment of achalasia: variables related to a good response. Dis Esophagus. 2014;27:18–23.

    Article  CAS  PubMed  Google Scholar 

  115. Zhang Y, Wang HJ, Chen XD, Liu L, Wang HB, Liu B, Guo J, Jia H. Per-oral endoscopic myotomy versus laparoscopic heller myotomy for achalasia: a meta-analysis of nonrandomized comparative studies. Medicine (Baltimore). 2016;95(6):1–6.

    Google Scholar 

  116. Bonatti H, Hinder RA, Klocker J, et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg. 2005;190(6):874–8.

    Article  PubMed  Google Scholar 

  117. Zaninotto G, Portale G, Costantini M, et al. Long term results (6-10 years) of laparoscopic fundoplication. J Gastrointest Surg. 2007;11(9):1138–45.

    Article  PubMed  Google Scholar 

  118. Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications and causes of death in patients with achalasia: results of a 33 year follow up investigation. Eur J Gastorenterol Hepatol. 2008;20(10):956–60.

    Article  Google Scholar 

  119. Nicodeme F, de Ruigh A, Xiao Y, et al. A comparison of symptom severity and bolus retention to Chicago classification esophageal pressure topography metrics in patients with achalasia. Clin Gastroenterol Hepatol. 2012;11:131–7.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Leeuwenburgh I, Scholten P, Alderliesten J, et al. Long-term esophageal cancer risk in patients with primary achalsia: a prospective study. Am J Gastroenterol. 2010;105:2144–9.

    Article  CAS  PubMed  Google Scholar 

  121. Ravi K, Geno DM, Katzka DA. Esophageal cancer screening in achalasia: is there a consensus? Dis Esophagus. 2015;28(3):299–304.

    Article  CAS  PubMed  Google Scholar 

  122. Boeckxstaens GE. Achalasia: from bench to peroral endoscopic myotomy. Dig Dis. 2016;34:476–82.

    Article  PubMed  Google Scholar 

  123. Fox M, Hebbard G, Janiak P, Brasseur JG, Ghosh S, Thumshirn M, Fried M, Schwizer W. High resolution manometry predicts the success of esophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil. 2004;16(5):533–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark Fox M.D., M.A. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Ang, D., Fox, M. (2018). Achalasia and Esophageal Outlet Obstruction. In: Bardan, E., Shaker, R. (eds) Gastrointestinal Motility Disorders . Springer, Cham. https://doi.org/10.1007/978-3-319-59352-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59352-4_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59350-0

  • Online ISBN: 978-3-319-59352-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics